National Institute of Mental Health; Notice of Meeting, 48998-48999 [2012-20055]
Download as PDF
<![CDATA[
48998
Federal Register / Vol. 77, No. 158 / Wednesday, August 15, 2012 / Notices
‘‘mPAL’’ (Mobile Personalized
Assessment and Learning), combines
mHealth-based educational functions
with the Ecological Momentary
Assessment (EMA) functions of TED
(transactional electronic diary) software.
mPAL allows interchange of data
obtained from EMA and learning system
in order to deliver context-aware
intervention in real time, customized to
the individual needs of participants.
mPAL enables participants to interact
with educational materials at the time
and place of their choosing and receive
personalized feedback when and where
it is most needed. The software
integrates into HuRlS where
comprehensive patient data can be
leveraged alongside the mPAL data to
provide better understanding of the
underlying factors under investigation.
Potential Commercial Applications:
• Substance abuse
• Drug abuse
• Alcoholism
• Behavioral modification
• Smoking cessation
• Pain management
Competitive Advantages:
• Low-cost mobile treatment
mechanism
• Provides personalized feedback to
patients at the time and place they
choose
• Proven usability in prior clinical
studies
Development Stage: Clinical
Inventors: Massoud R. Vahabzadeh,
Mustapha Mezghanni, and Jia-Ling Lin
(all of NIDA)
Publications:
srobinson on DSK4SPTVN1PROD with NOTICES
1. Vahabzadeh M, et al. PGIS: Electronic
diary data integration with GPS data initial
application in substance-abuse patients. In,
Proc. 23rd IEEE International Symposium on
Computer-Based Medical Systems, pp 474–9,
2010. [DOI: 10.1109/CBMS.2010.6042691]
2. Lin JL, et al. A high-level specification
for adaptive ecological momentary
assessment: real-time assessment of drug
craving, use and abstinence. AMIA Annu
Symp Proc. 2005:455–9. [PMID 16779081]
3. Vahabzadeh M, et al. An electronic diary
software for ecological momentary
assessment (EMA) in clinical trials. In, Proc.
17th IEEE International Symposium on
Computer-Based Medical Systems, pp 167–
72, 2004. [DOI: 10.1109/
CBMS.2004.1311709]
Intellectual Property: HHS Reference
No. E–195–2012/0—Software. Patent
protection is not being pursued for this
technology.
Licensing Contact: Michael
Shmilovich; 301–435–5019;
shmilovm@mail.nih.gov.
Collaborative Research Opportunity:
The NIDA, IRP, Biomedical Informatics
Section, is seeking statements of
capability or interest from parties
VerDate Mar<15>2010
17:49 Aug 14, 2012
Jkt 226001
interested in collaborative research to
further develop, evaluate or
commercialize Mobile Personalized
Assessment & Learning for Addiction
Treatment and Behavioral Modification.
For collaboration opportunities, please
contact Vio Conley at
conleyv@mail.nih.gov.
Dated: August 10, 2012.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
Plasmid Useful in Transplantation
Therapy for Age-Related Eye Disease
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Description of Technology:
Researchers have developed a green
fluorescent protein (GFP) based plasmid
that can be used to detect differentiated
retinal pigment epithelium (RPE) cells.
RPE is a layer of cells located behind the
eye that becomes damaged in agerelated macular degeneration (AMD).
Current cell based therapies for treating
AMD focus on generating RPE cells from
stem cells. This GPF-based plasmid can
be inserted into growing stem cells, and
the fluorescence marker can be used to
detect and purify stem cells
differentiating into RPE cells. This
advancement allows generation of a
purified population of RPE cells for in
vitro and transplantation purposes.
Additionally, cells comprising the
GFP-based construct may be useful in
high-throughput drug screening as a
means to: (1) identify potential
therapeutic targets of RPE degenerative
diseases such as AMD, and (2) evaluate
initial toxicity of candidate drugs in
RPE cells.
Potential Commercial Applications:
• Fluorescence based marker for
detecting and purifying differentiated
RPE cells
• Potential use in high throughput
drug screening
Competitive Advantages: GFP based
marker allows for fast and simple
detection of differentiated RPE cells
from stem cells.
Development Stage:
• Prototype
• In vitro data available
Inventors: Kapil Bharti (NINDS),
Heinz Arnheiter (NINDS), Sheldon
Millier (NEI)
Publication: Bharti K, et al. The new
paradigm: retinal pigment epithelium
cells generated from embryonic or
induced pluripotent stem cells. Pigment
Cell Melanoma Res. 2011 Feb;24(1):21–
34. [PMID 20846177]
Intellectual Property: HHS Reference
No. E–054–2012/0—Research Tool.
Patent protection is not being pursued
for this technology.
Licensing Contact: Lauren NguyenAntczak, Ph.D., J.D.; 301–435–4074;
lauren.nguyen-antczak@nih.gov.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
[FR Doc. 2012–20059 Filed 8–14–12; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Mental Health
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: September 13, 2012.
Open: 8:30 a.m. to 2 p.m.
Agenda: Presentation of NIMH Director’s
report and discussion on NIMH program and
policy issues.
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Closed: 2:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Contact Person: Jane A. Steinberg, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Mental Health, NIH,
Neuroscience Center, 6001 Executive Blvd.,
Room 6154, MSC 9609, Bethesda, MD 20892–
9609, 301–443–5047.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
E:\FR\FM\15AUN1.SGM
15AUN1
Federal Register / Vol. 77, No. 158 / Wednesday, August 15, 2012 / Notices
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, visitors will be
asked to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nimh.nih.gov/about/advisory-boardsand-groups/namhc/index.shtml, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Translational Research
Review.
Date: August 23, 2012.
Time: 4:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Ernest W. Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Suite 3208, MSC 9529, Bethesda, MD
20892–9529, 301–496–4056,
lyonse@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 8, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–20055 Filed 8–14–12; 8:45 am]
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
srobinson on DSK4SPTVN1PROD with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
17:49 Aug 14, 2012
Jkt 226001
[FR Doc. 2012–20052 Filed 8–14–12; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
BILLING CODE 4140–01–P
VerDate Mar<15>2010
Dated: August 8, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00052
Fmt 4703
Sfmt 9990
48999
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: September 20–21, 2012.
Open: September 20, 2012, 8 a.m. to 2:15
p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research; and Administrative and
Program Developments.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 6, Bethesda, MD 20892.
Closed: September 20, 2012, 2:15 p.m. to
5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 6, Bethesda, MD 20892.
Closed: September 21, 2012, 8 a.m. to 11
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, Ph.D.,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https:///
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: August 8, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–20048 Filed 8–14–12; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\15AUN1.SGM
15AUN1
]]>Agencies
[Federal Register Volume 77, Number 158 (Wednesday, August 15, 2012)]
[Notices]
[Pages 48998-48999]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20055]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Mental Health Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Mental Health Council.
Date: September 13, 2012.
Open: 8:30 a.m. to 2 p.m.
Agenda: Presentation of NIMH Director's report and discussion on
NIMH program and policy issues.
Place: National Institutes of Health Neuroscience Center, 6001
Executive Boulevard, Conference Room C/D/E, Rockville, MD 20852.
Closed: 2:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications
Place: National Institutes of Health Neuroscience Center, 6001
Executive Boulevard, Conference Room C/D/E, Rockville, MD 20852.
Contact Person: Jane A. Steinberg, Ph.D., Director, Division of
Extramural Activities, National Institute of Mental Health, NIH,
Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609,
Bethesda, MD 20892-9609, 301-443-5047.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this
[[Page 48999]]
notice at least 10 days in advance of the meeting. Interested
individuals and representatives of organizations may submit a letter
of intent, a brief description of the organization represented, and
a short description of the oral presentation. Only one
representative of an organization may be allowed to present oral
comments and if accepted by the committee, presentations may be
limited to five minutes. Both printed and electronic copies are
requested for the record. In addition, any interested person may
file written comments with the committee by forwarding their
statement to the Contact Person listed on this notice. The statement
should include the name, address, telephone number and when
applicable, the business or professional affiliation of the
interested person.
In the interest of security, visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/index.shtml, where an agenda and any additional information
for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.242,
Mental Health Research Grants; 93.281, Scientist Development Award,
Scientist Development Award for Clinicians, and Research Scientist
Award; 93.282, Mental Health National Research Service Awards for
Research Training, National Institutes of Health, HHS)
Dated: August 8, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-20055 Filed 8-14-12; 8:45 am]
BILLING CODE 4140-01-P
